Lateral flow test

Avacta’s Rapid Antigen Test Is Confirmed to Detect SARS-CoV-2 New Variants

Retrieved on: 
Monday, March 8, 2021
Research, Infectious diseases, Clinical trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Other Science, Coronaviridae, Medicine, Sarbecovirus, Clinical medicine, Rapid antigen test, Affimer, Lineage B.1.1.7, Peplomer, Lateral flow test, Severe acute respiratory syndrome coronavirus 2, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome

Some of these variants are more infectious, and therefore more rapidly transmissible, and have the potential to become dominant strains.

Key Points: 
  • Some of these variants are more infectious, and therefore more rapidly transmissible, and have the potential to become dominant strains.
  • Avacta has carried out analytical tests with the spike proteins isolated from both the B117 and D614G variants, and has confirmed that its AffiDX SARS-CoV-2 rapid antigen lateral flow test detects both of these variants as well as the original strain.
  • We will continue to monitor the performance of the Affimer reagents with future dominant variants as they become available to us.
  • Disclaimer: AffiDX SARS-CoV-2 Lateral Flow Rapid Antigen Test not currently for sale in the United States.

The Worldwide Point of Care/Rapid Diagnostics Industry is Projected to Reach $50.6 Billion by 2025 at a CAGR of 11.4% from 2020

Retrieved on: 
Thursday, March 4, 2021
Chromatography, Lateral flow test

The global point of care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%.

Key Points: 
  • The global point of care diagnostics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%.
  • Factors such as the technological advancements in point of care devices in the market are propelling the growth of the market.
  • The lateral flow assays segment accounted for the largest share of the point of care diagnostics market, by platform, in 2020.
  • The lateral flow assays segment accounted for the largest share of the point of care diagnostics market in 2020.

Global Lateral Flow Assays Market (2020 to 2025) - Evolving Applications of Lateral Flow Assays Present Opportunities

Retrieved on: 
Thursday, February 25, 2021
Natural sciences, Chemistry, Physical sciences, Laboratory techniques, Immunologic tests, Chromatography, Lateral flow test, Assay, Multiplex, AutoAnalyzer, Immunoassay

Based on applications, the lateral flow assays market is broadly segmented into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing.

Key Points: 
  • Based on applications, the lateral flow assays market is broadly segmented into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing.
  • In the lateral flow assay kits & reagents by technique segment, sandwich assays holds the highest market share
    On the basis of technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays.
  • Based on sample type, the lateral flow assays market for clinical testing applications is segmented into blood, urine, saliva, and other samples.
  • North America is expected to account for the largest share of the global lateral flow assays market in 2019.

The Worldwide Lateral Flow Assays Industry is Expected to Reach $10.2 billion by 2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 22, 2021
Science, Health, Research, Medical devices, Laboratory techniques, Natural sciences, Chemistry, Physical sciences, Immunologic tests, Assay, Biochemistry, Titration, Lateral flow test, Multiplex

The global lateral flow assays market is projected to reach USD 10,230.3 million by 2025 from USD 8,205.3 million in 2020, at a CAGR of 4.5% during the forecast period.

Key Points: 
  • The global lateral flow assays market is projected to reach USD 10,230.3 million by 2025 from USD 8,205.3 million in 2020, at a CAGR of 4.5% during the forecast period.
  • Wide applications of lateral flow assays in food safety and environment testing promote the growth of this segment in the forecast period.
  • In the lateral flow assay kits & reagents by technique segment, sandwich assays holds the highest market share
    On the basis of technique, the lateral flow assay kits & reagents market is segmented into competitive assays, sandwich assays, and multiplex detection assays.
  • North America is expected to account for the largest share of the global lateral flow assays market in 2019.

Abingdon Health signs collaboration and co-marketing agreement with Abcam

Retrieved on: 
Tuesday, February 9, 2021
Abcam, Immunologic tests, Abingdon Health, Lateral flow test, Abingdon, Colloidal gold, Companies of the United Kingdom, Medicine, Health care

York, and Cambridge U.K. 09 February 2021: Abingdon Health (AIM:ABDX) (Abingdon or the Company), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a collaboration and co-marketing agreement with Abcam plc (NASDAQ:ABCM; AIM:ABC) (Abcam), a global leader in the supply of life science research tools and reagents.

Key Points: 
  • York, and Cambridge U.K. 09 February 2021: Abingdon Health (AIM:ABDX) (Abingdon or the Company), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a collaboration and co-marketing agreement with Abcam plc (NASDAQ:ABCM; AIM:ABC) (Abcam), a global leader in the supply of life science research tools and reagents.
  • Under the terms of the agreement, Abcam will be the preferred supplier to Abingdon of gold nanoparticles and custom conjugation reagents and services, for the Companys lateral flow assays.
  • We also look forward to working with Abcam to identify and service their customers lateral flow contract development and manufacturing requirements.
  • Mennah Moustafa, Abcams VP of Business Development, commented We are excited to be collaborating with Abingdon Health to provide critical components for their lateral flow tests.

Companies Prepare For A New Year Return With Covid-19 Lateral Flow Antigen Testing

Retrieved on: 
Monday, December 21, 2020
Medicine, Immunologic tests, Clinical medicine, Medical specialties, Zoonoses, Chromatography, Lateral flow test, ELISA, Coronavirus disease, Medical terminology, COVID-19 testing

LONDON, Dec. 21, 2020 /PRNewswire/ -- Demand from UK businesses for AlphaBiolabs' Covid-19 lateral flow antigen testing kit has soared ahead of the new year.

Key Points: 
  • LONDON, Dec. 21, 2020 /PRNewswire/ -- Demand from UK businesses for AlphaBiolabs' Covid-19 lateral flow antigen testing kit has soared ahead of the new year.
  • The lateral flow antigen test can detect an active case of Covid-19 after the onset of symptoms or from 14 days after initial exposure to the virus.
  • The rapid lateral flow antigen test is carried out on-site by taking samples from the nose and throat.
  • Photographs of David Thomas are attached along with images of the Covid-19 lateral flow testing kit's screening cassette.

Coronavirus (COVID-19) Update: FDA Authorizes Antigen Test as First Over-the-Counter Fully At-Home Diagnostic Test for COVID-19

Retrieved on: 
Tuesday, December 15, 2020
Medicine, Immunologic tests, Clinical medicine, Medical specialties, COVID-19 testing, ELISA, Coronavirus disease, Lateral flow test, Viral disease testing

The Ellume COVID-19 Home Test is a rapid, lateral flowantigen test, a type of test that runs a liquid sample along a surface with reactive molecules.

Key Points: 
  • The Ellume COVID-19 Home Test is a rapid, lateral flowantigen test, a type of test that runs a liquid sample along a surface with reactive molecules.
  • The Ellume COVID-19 Home Test is the first COVID-19 test that can be used completely at home without a prescription.
  • "This test, like other antigen tests, is less sensitive and less specific than typical molecular tests run in a lab.
  • Similar to other antigen tests, a small percentage of positive and negative results from this test may be false.

Neogen launches quick, easy tests for meat speciation

Retrieved on: 
Monday, December 14, 2020
Evolutionary biology, Biology, Ecology, Branches of biology, Neogen, Lateral flow test, Speciation, Nature

LANSING, Mich., Dec. 14, 2020 /PRNewswire/ --Neogen Corporation (NASDAQ: NEOG) has developed the quickest and easiest tests available to determine meat speciation in raw meat and environmental samples.

Key Points: 
  • LANSING, Mich., Dec. 14, 2020 /PRNewswire/ --Neogen Corporation (NASDAQ: NEOG) has developed the quickest and easiest tests available to determine meat speciation in raw meat and environmental samples.
  • The new tests join Neogen's existing Reveal for Pork in the company's simple and quick meat speciation test range.
  • The new tests follow Neogen's very easy Reveal format, which utilizes lateral flow test strips to produce easy-to-interpret results.
  • Neogen's full line of meat speciation products also includes BioKits tests for species identification, which provide sensitive and specific qualitative detection of a range of animal species.

ams Wins Federal Funding in Austria to Bolster Pandemic Control Through a Highly-accurate, Cloud-connected Lateral Flow Test Device for SARS-CoV-2 (COVID-19) Providing Test Results in Around 15 Minutes

Retrieved on: 
Tuesday, December 1, 2020
Biotechnology, Internet, Health, Medical devices, Infectious diseases, Technology, Semiconductor, Mobile, Wireless, Articles, Eureka, Lateral flow test, Logistics, Organizations

ams is honored to participate in the EUREKA funding program and join the Federal Ministries in the fight against the pandemic.

Key Points: 
  • ams is honored to participate in the EUREKA funding program and join the Federal Ministries in the fight against the pandemic.
  • EUREKA is the worlds biggest public network for international cooperation in R&D and innovation, present in over 45 countries via national funding agencies.
  • The cloud-connected rapid Lateral Flow Test solution from ams and its partners can be produced at scale to support wide-spread availability.
  • The solution digitizes the result from the lateral flow test strips eliminating complicated logistics and clinical processing.

Lateral Flow Assays Market worth $10.2 billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Tuesday, November 17, 2020
Natural sciences, Chemistry, Physical sciences, Laboratory techniques, Immunologic tests, Chromatography, Lateral flow test, Assay, Multiplex

However, other reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key factors restraining the growth of the market.

Key Points: 
  • However, other reluctance among doctors and patients to change existing diagnostic procedures and the low accuracy of lateral flow assays are the key factors restraining the growth of the market.
  • The lateral flow readers segment is further segmented into digital/handheld readers, bench top readers, and mobile/smartphone readers.
  • In case of lateral flow assays kits & reagents, by technique, the sandwich assays segment is expected to hold the highest share in the market during the forecast period
    On the basis of technique, the Lateral Flow Assays kits & reagents market is segmented into sandwich assays, competitive assays, and multiplex detection assays.
  • By Type, Lateral Flow Assays is segment in to Blood Samples, Urine Samples, Saliva Samples and Other Samples.